Imricor Medical Systems, Inc. (ASX: IMR)
Australia
· Delayed Price · Currency is AUD 0.925
-0.015 (-1.60%)
Nov 21, 2024, 4:10 PM AEST
Imricor Medical Systems Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Revenue | 0.82 | 0.62 | 0.82 | 0.7 | 0.7 | 0.64 | Upgrade
|
| Revenue Growth (YoY) | 72.79% | -24.56% | 17.20% | -0.84% | 9.76% | -36.19% | Upgrade
|
| Cost of Revenue | 1.74 | 1.73 | 2.34 | 2.59 | 1.1 | 0.38 | Upgrade
|
| Gross Profit | -0.91 | -1.12 | -1.53 | -1.9 | -0.4 | 0.26 | Upgrade
|
| Selling, General & Admin | 7.08 | 7.82 | 7.79 | 8.69 | 6.01 | 3.21 | Upgrade
|
| Research & Development | 7.8 | 7.92 | 7.95 | 9.68 | 5.55 | 3.6 | Upgrade
|
| Operating Expenses | 14.88 | 15.74 | 15.73 | 18.36 | 11.56 | 6.81 | Upgrade
|
| Operating Income | -15.8 | -16.86 | -17.26 | -20.26 | -11.96 | -6.55 | Upgrade
|
| Interest Expense | -0.03 | -0.05 | -0.18 | -0.11 | -0.3 | -1.03 | Upgrade
|
| Interest & Investment Income | 0.06 | 0.06 | 0.11 | 0.02 | 0.03 | 0.01 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.03 | 0.01 | -0.02 | -0.04 | -0.2 | 0.22 | Upgrade
|
| Other Non Operating Income (Expenses) | -4.53 | -5.79 | -0.01 | -0.1 | -0.02 | -1.82 | Upgrade
|
| EBT Excluding Unusual Items | -20.26 | -22.63 | -17.36 | -20.49 | -12.45 | -9.16 | Upgrade
|
| Other Unusual Items | - | - | - | 0.76 | - | -4.13 | Upgrade
|
| Pretax Income | -20.26 | -22.63 | -17.36 | -19.73 | -12.45 | -13.29 | Upgrade
|
| Net Income | -20.26 | -22.63 | -17.36 | -19.73 | -12.45 | -13.29 | Upgrade
|
| Net Income to Common | -20.26 | -22.63 | -17.36 | -19.73 | -12.45 | -13.29 | Upgrade
|
| Shares Outstanding (Basic) | 176 | 157 | 146 | 131 | 110 | 61 | Upgrade
|
| Shares Outstanding (Diluted) | 176 | 157 | 146 | 131 | 110 | 61 | Upgrade
|
| Shares Change (YoY) | 17.63% | 7.46% | 11.42% | 18.76% | 81.97% | 44.12% | Upgrade
|
| EPS (Basic) | -0.12 | -0.14 | -0.12 | -0.15 | -0.11 | -0.22 | Upgrade
|
| EPS (Diluted) | -0.12 | -0.14 | -0.12 | -0.15 | -0.11 | -0.22 | Upgrade
|
| Free Cash Flow | -14.83 | -13.06 | -16.75 | -18.11 | -12.97 | -6.99 | Upgrade
|
| Free Cash Flow Per Share | -0.08 | -0.08 | -0.11 | -0.14 | -0.12 | -0.12 | Upgrade
|
| Gross Margin | -110.81% | -181.27% | -187.10% | -272.30% | -56.64% | 41.01% | Upgrade
|
| Operating Margin | -1916.15% | -2738.12% | -2115.18% | -2909.72% | -1702.78% | -1023.50% | Upgrade
|
| Profit Margin | -2458.30% | -3675.61% | -2126.96% | -2834.05% | -1772.60% | -2078.14% | Upgrade
|
| Free Cash Flow Margin | -1799.58% | -2121.66% | -2052.56% | -2601.63% | -1847.52% | -1093.12% | Upgrade
|
| EBITDA | -15.07 | -16.15 | -16.55 | -19.57 | -11.43 | -6.29 | Upgrade
|
| D&A For EBITDA | 0.72 | 0.71 | 0.71 | 0.69 | 0.53 | 0.26 | Upgrade
|
| EBIT | -15.8 | -16.86 | -17.26 | -20.26 | -11.96 | -6.55 | Upgrade
|
| Revenue as Reported | 0.82 | 0.62 | 0.82 | 0.7 | 0.7 | 0.64 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.